| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 10/25/2007 | US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase |
| 10/25/2007 | US20070248598 Recombinant anti-VLA4 antibody molecules |
| 10/25/2007 | US20070248577 Methods and compositions for administering stem cells |
| 10/25/2007 | CA2649735A1 Activating agent for peroxisome proliferator activated receptor .delta. |
| 10/25/2007 | CA2649150A1 Thioxanthine derivatives and their use as inhibitors of mpo |
| 10/25/2007 | CA2648239A1 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis |
| 10/25/2007 | CA2645362A1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists |
| 10/24/2007 | EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 10/24/2007 | EP1847543A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 10/24/2007 | EP1847256A1 Antibacterial compositions for the treatment of infections of the upper and lower airways |
| 10/24/2007 | EP1846409A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 10/24/2007 | EP1846390A1 Novel 6-pyridylphenanthridines |
| 10/24/2007 | EP1846387A2 Bis-(coumarin) compounds with anti-inflammatory activity |
| 10/24/2007 | EP1846370A2 2-METHYLENE-19-NOR-1&agr;-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 10/24/2007 | EP1846369A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 10/24/2007 | EP1846037A1 Methods of treating various conditions by administration of sustained release l-arginine |
| 10/24/2007 | EP1845994A1 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 10/24/2007 | EP1845992A1 Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis |
| 10/24/2007 | EP1207860B1 Controlled release pellet formulation |
| 10/24/2007 | EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase |
| 10/24/2007 | CN101060852A Oral inactivation vaccine and its delivery method |
| 10/24/2007 | CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 10/24/2007 | CN101057905A Microwave extraction method for cordate houttuynia total flavones |
| 10/24/2007 | CN101057902A Medicine and its quality control method |
| 10/24/2007 | CN101057899A Effective prescription for food therapeutic and cough relieving |
| 10/24/2007 | CN101057889A Compound with mulberry as main material products and its preparation technology |
| 10/24/2007 | CN101057881A Medicine for treating laryngopharyngitis and intractable headache |
| 10/24/2007 | CN101057866A Method for preparing 'kelike' capsule |
| 10/24/2007 | CN101057865A Method for preparing 'youkadan' granule |
| 10/24/2007 | CN101057853A Antiadhesive carbohydrates |
| 10/24/2007 | CN101057841A 'Yanhuning' frozen-dried powder injection and its preparation method |
| 10/24/2007 | CN101057840A Application of Vam3 in preparing medicine for treating chronic obstructive disease of lung |
| 10/24/2007 | CN101057626A Sichuan fritillary bulb mint plum and its producing method |
| 10/24/2007 | CN101057619A Help producing saliva and slaking thirst, softening blood vessel, promoting blood circulation health tea |
| 10/24/2007 | CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 10/24/2007 | CN100344646C Oligonucleotide-containing pharmacological compositions and their use |
| 10/24/2007 | CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 10/24/2007 | CN100344632C 稠合的呋喃化合物 Fused furan compound |
| 10/24/2007 | CN100344300C Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method |
| 10/24/2007 | CN100344298C Method for preparing eupatorium powder |
| 10/24/2007 | CN100344284C Use of Abidol in preparing medicines for treating and preventing SARS virus |
| 10/24/2007 | CN100344235C Throat-moistening and health-care biscuit |
| 10/23/2007 | US7285680 β-alanine derivatives and the use thereof |
| 10/23/2007 | US7285676 Synthesis of chiral 2-alkyl amino acids |
| 10/23/2007 | US7285670 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-thiazole-4(S)-carboxylic acid by coupling a mono- or polyalkoxybenzonitrile with a cysteine ester and alkylating the thiazoline ring at the 4-carbon position; preferably a phase transfer agent such as N-9-anthracenylmethylcinchonidinium chloride is used |
| 10/23/2007 | US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same |
| 10/23/2007 | US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity |
| 10/23/2007 | US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1) |
| 10/23/2007 | US7285561 Imidazo-substituted compounds as p38 kinase inhibitors |
| 10/23/2007 | US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis |
| 10/23/2007 | US7285559 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease. |
| 10/23/2007 | US7285549 Sulfamides and their use as endothelin receptor antagonists |
| 10/23/2007 | US7285382 Compositions and methods for treatment of cancer |
| 10/23/2007 | US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections |
| 10/23/2007 | CA2248266C Immunosuppressive compounds and methods |
| 10/18/2007 | WO2007118198A2 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 10/18/2007 | WO2007116916A1 Liquid drug preparation for oral administration |
| 10/18/2007 | WO2007116106A1 Novel compounds as antagonists of adenosine a1 receptors |
| 10/18/2007 | WO2007115931A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors |
| 10/18/2007 | WO2007115822A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
| 10/18/2007 | WO2007092574A3 Crystalline forms of ciclesonide |
| 10/18/2007 | WO2007087524A3 Treatment of acute respiratory distress syndrome |
| 10/18/2007 | WO2007076228A8 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders |
| 10/18/2007 | WO2007075629A3 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 10/18/2007 | WO2007059507A3 Compositions comprising lipoxygenase inhibitors and cyclodextrin |
| 10/18/2007 | WO2007031933A3 Stable pharmaceutical composition comprising a pyrimidine-sulfamide |
| 10/18/2007 | US20070244185 Crystal form and pharmaceutical compositions of (+)-R-zileuton |
| 10/18/2007 | US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase |
| 10/18/2007 | US20070244133 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine |
| 10/18/2007 | US20070244128 5-lipoxygenase-activating protein (flap) inhibitors |
| 10/18/2007 | US20070244068 2',3'-O-methylenestyryl-5'-alpha-(carboxymethylenephosphono)-N6-ethylaminocarbonyl-adenosine phosphate; modified mononucleoside phosphate by attaching degradation-resistant substituent on terminal phosphate; increase rate & total amount of mucin secretion; epithelial tissue, platelet aggregation diseases |
| 10/18/2007 | US20070244045 Treatment of Acute Respiratory Distress Syndrome |
| 10/18/2007 | US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 10/18/2007 | US20070243260 Treatment of Childhood Asthma |
| 10/18/2007 | US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 10/18/2007 | US20070243175 Methods and compositions for regenerating tissue |
| 10/18/2007 | US20070243174 Methods and compositions for directing stem cells to the liver |
| 10/18/2007 | US20070243173 Methods and compositions for directing stem cells to the heart |
| 10/18/2007 | DE102006017320A1 Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant |
| 10/18/2007 | DE102005053317B4 Verwendung einer Zusammensetzung mit einem Gemisch pflanzlicher Extrakte aus Fenchel, Thymian und Eukalyptus Use of a composition comprising a mixture of vegetable extracts of fennel, thyme and eucalyptus |
| 10/18/2007 | CA2853611A1 High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| 10/18/2007 | CA2651898A1 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 10/18/2007 | CA2648324A1 2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 10/18/2007 | CA2647292A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors |
| 10/18/2007 | CA2646578A1 Novel formulations |
| 10/17/2007 | EP1845104A1 Par-2 agonist |
| 10/17/2007 | EP1845093A1 A new crystalline and stable form of andolast |
| 10/17/2007 | EP1845091A1 Process for producing muscarine receptor antagonist and intermediate therefor |
| 10/17/2007 | EP1844784A1 A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system |
| 10/17/2007 | EP1844773A1 Percutaneous absorption preparation |
| 10/17/2007 | EP1844767A2 Epoxide hydrolase complexes and methods therewith |
| 10/17/2007 | EP1844051A1 Thienopyrroles useful in the treatment of inflammation |
| 10/17/2007 | EP1844050A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 10/17/2007 | EP1844040A1 Crystalline forms of cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido)cyclohexyl]-2-(tetrahydrothiopyran-4-yloxy)nicotinamide |
| 10/17/2007 | EP1844013A1 Indoles useful in the treatment of inflammation |
| 10/17/2007 | EP1844011A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 10/17/2007 | EP1844003A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor |
| 10/17/2007 | EP1844001A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 10/17/2007 | EP1843789A2 Compositions and methods for treating fibrotic disorders |
| 10/17/2007 | EP1843781A1 Composition for prevention, treatment and diagnosis of chronic inflammatory airway diseases |